Key result
Aging and AD linked to attenuated scale invariance of daytime activity fluctuations.
Cross-Sectional (n=65)
Aging and Alzheimer's disease significantly attenuate the scale invariance of activity fluctuations over multiple time scales, potentially reflecting functional changes in the suprachiasmatic nucleus.
Answers are grounded in this paper and cite their sources.
May support activity-based AD biomarkers; leaves open prospective validation before clinical use.
Human motor control systems orchestrate complex scale-invariant patterns of activity over a wide range of time scales (minutes to hours). The neural mechanisms underlying scale-invariance are unknown in humans. In rats, the master circadian pacemaker [suprachiasmatic nucleus (SCN)] is crucially involved in scale-invariant activity fluctuations over multiple time scales from minutes to 24 h. Aging and Alzheimer's disease (AD) are associated with progressive dysfunction of the SCN. Thus, if the SCN is responsible for the scale-invariant activity fluctuations in humans, we predict disturbances of scale-invariant activity fluctuations in elderly humans and even more pronounced disturbances in elderly humans with AD. To test these hypotheses, we studied spontaneous daytime activity patterns in 13 young adults (mean +/- SD: 25.5 +/- 6.1 y); 13 elderly people with early-stage AD (68.5 +/- 6.1 y) matched with 13 elderly controls (68.6 +/- 6.1 y); and 14 very old people with late-stage AD (83.9 +/- 6.7 y) matched with 12 very old controls (80.8 +/- 8.6 y). In young adults, activity exhibited robust scale-invariant correlations across all tested time scales (minutes to 8 h). The scale-invariant correlations at 1.5-8 h declined with age (P = 0.01) and were significantly reduced in the elderly (P = 0.04) and very old controls (P = 0.02). Remarkably, an age-independent AD effect further reduced the scale-invariant correlations at 1.5-8 h (P = 0.04), leading to the greatest reduction of the scale-invariant correlations in very old people with late-stage AD-resembling closely the loss of correlations at large time scales in SCN-lesioned animals. Thus, aging and AD significantly attenuate the scale invariance of activity fluctuations over multiple time scales. This attenuation may reflect functional changes of the SCN.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2009) conducted a cross-sectional in Alzheimer's disease (n=65). Aging and Alzheimer's disease vs. Young adults and age-matched controls was evaluated on Scale-invariant correlations of activity fluctuations at 1.5-8 h (p=0.04). Aging and Alzheimer's disease significantly attenuated the scale invariance of daytime activity fluctuations at 1.5-8 hours (P=0.01 for age decline; P=0.04 for independent AD effect).
Synapse has enriched 10 related papers. Consider them for comparative context: